Literature DB >> 19885280

United Kingdom prospective diabetes study follow-up studies establish a legacy effect of therapy for hyperglycemia but not hypertension.

David C Klonoff.   

Abstract

Entities:  

Keywords:  UKPDS; diabetes; hyperglycemia; hypertension; legacy; therapy

Year:  2008        PMID： 19885280      PMCID： PMC2769819          DOI： 10.1177/193229680800200601

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  5 in total

1.  Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; H Andrew W Neil; David R Matthews
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

2.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

3.  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

Authors: 
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

4.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

5.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  5 in total
  3 in total

1.  Transgenerational Karma.

Authors:  Bharti Kalra; Sanjay Kalra; A G Unnikrishnan; Manash P Baruah; Deepak Khandelwal; Yashdeep Gupta
Journal:  Indian J Endocrinol Metab       Date:  2017 Mar-Apr

2.  Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.

Authors:  Alison R Meloni; Mary Beth DeYoung; Jenny Han; Jennie H Best; Michael Grimm
Journal:  Cardiovasc Diabetol       Date:  2013-03-23       Impact factor: 9.951

3.  Transition of a Text-Based Insulin Titration Program From a Randomized Controlled Trial Into Real-World Settings: Implementation Study.

Authors:  Natalie Koch Levy; Natasha A Orzeck-Byrnes; Sneha R Aidasani; Dana N Moloney; Lisa H Nguyen; Agnes Park; Lu Hu; Aisha T Langford; Binhuan Wang; Mary Ann Sevick; Erin S Rogers
Journal:  J Med Internet Res       Date:  2018-03-19       Impact factor: 5.428
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.